Efficacy/Safety of Telmisartan/Amlodipine/Rosuvastatin in Hypertensive Patients With Hyperlipidemia

Clinical trial NCT03566316 · COMPLETED

Trial details

NCT number: NCT03566316
Sponsor: IlDong Pharmaceutical Co Ltd
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Hypertension With Hyperlipidemia

Start date: 2015-11-24
Primary completion: 2017-06-16
Enrollment: 134

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.